Classification and diagnostic investigation in inflammatory myopathies: A study of 99 patients

Journal of Rheumatology

Volumn 40, Issue 7, 2013, Pages 1173-1182

  Danielsson, Olof ^a   Lindvall, Bjorn ^b   Gati, Istvan ^a   Ernerudh, Jan ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dermatomyositis; Idiopathic Inflammatory Myopathies; Inclusion Body Myositis; Inflammatory Myopathies; Polymyositis

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PARAFFIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; DERMATOMYOSITIS; DERMATOMYOSITIS SINE DERMATITIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; EMBEDDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE MEDIATED NECROTIZING MYOPATHY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

DERMATOMYOSITIS; IDIOPATHIC INFLAMMATORY MYOPATHIES; INCLUSION BODY MYOSITIS; INFLAMMATORY MYOPATHIES; POLYMYOSITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; RETROSPECTIVE STUDIES;

EID: 84879918296     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120804     Document Type: Article

References (26)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-407.
3. Chou SM. Myxovirus-like structures and accompanying nuclear changes in chronic polymyositis. Arch Pathol 1968;86:649-658.
4. Chou SM. Inclusion body myositis. Baillieres Clin Neurol 1993;2:557-577.
5. Chou SM, Gutmann L. Picornavirus-like crystals in subacute polymyositis. Neurology 1970;20:205-213.
6. Sato T, Walker DL, Peters HA, Resse HH, Chou SM. Chronic polymyositis and myxovirus-like inclusions. Electron microscopic and viral studies. Arch Neurol 1971;24:409-418.
7. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR,et al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14:337-345.
8. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JK, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713.
9. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: Epidemiology, classification, and diagnostic criteria [review]. Rheum Dis Clin North Am 2002;28:723-41.
10. Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995;22:668-74.
11. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: Analysis of 100 French Canadian patients. Medicine 2005;84:231-49.
12. Chahin N, Engel AG. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008;70:418-24.
13. van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: An overdiagnosed entity. Neurology 2003;61:316-21.
14. Karpati G. Skeletal muscular pathology in neuromuscular diseases. In: Goetz CG, Tanner CM, Aminoff MJ, editors. Myopathies. Amsterdam: Elsevier; 1992:44-5.
15. Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, et al. Inclusion body myositis: Clinical and pathological boundaries. Ann Neurol 1996;40:581-6.
16. Lindvall B, Bengtsson A, Ernerudh J, Eriksson P. Subclinical myositis is common in primary Sjogren's syndrome and is not related to muscle pain. J Rheumatol 2002;29:717-25.
17. Engel WK, Cunningham GG. Rapid examination of muscle tissue. An improved trichrome method for fresh-frozen biopsy sections. Neurology 1963;13:919-23.
18. Puchtler H. Alkaline Congo red. J Histochem Cytochem 1962;10:355-64.
19. Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ. Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003;27:407-25.
20. van der Pas J, Hengstman GJ, ter Laak HJ, Borm GF, van Engelen BG. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 2004;75:136-9.
21. Salaroli R, Baldin E, Papa V, Rinaldi R, Tarantino L, De Giorgi LB, et al. Validity of internal expression of the major histocompatibility complex class I in the diagnosis of inflammatory myopathies. J Clin Pathol 2012;65:14-9.
22. Danielsson O, Nilsson C, Lindvall B, Ernerudh J. Expression of apoptosis related proteins in normal and diseased muscle: A possible role for Bcl-2 in protection of striated muscle. Neuromusc Disord 2009;19:412-7.
23. Henriksson KG, Sandstedt P. Polymyositis-treatment and prognosis. A study of 107 patients. Acta Neurol Scand 1982;65:280-300.
24. Pestronk A. Acquired immune and inflammatory myopathies: Pathologic classification. Curr Opin Rheumatol 2011;23:595-604.
25. Liang C, Needham M. Necrotizing autoimmune myopathy. Curr Opin Rheumatol 2011;23:612-9.
26. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme. A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713-21.